JP7245399B2 - 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物 - Google Patents

血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物 Download PDF

Info

Publication number
JP7245399B2
JP7245399B2 JP2022565919A JP2022565919A JP7245399B2 JP 7245399 B2 JP7245399 B2 JP 7245399B2 JP 2022565919 A JP2022565919 A JP 2022565919A JP 2022565919 A JP2022565919 A JP 2022565919A JP 7245399 B2 JP7245399 B2 JP 7245399B2
Authority
JP
Japan
Prior art keywords
decanoic acid
blood
acid
agent
increasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022565919A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022202566A5 (https=
JPWO2022202566A1 (https=
Inventor
祥伍 辻野
哲雄 高木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oillio Group Ltd
Original Assignee
Nisshin Oillio Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oillio Group Ltd filed Critical Nisshin Oillio Group Ltd
Publication of JPWO2022202566A1 publication Critical patent/JPWO2022202566A1/ja
Publication of JPWO2022202566A5 publication Critical patent/JPWO2022202566A5/ja
Priority to JP2023037718A priority Critical patent/JP7520175B2/ja
Application granted granted Critical
Publication of JP7245399B2 publication Critical patent/JP7245399B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
JP2022565919A 2021-03-26 2022-03-16 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物 Active JP7245399B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023037718A JP7520175B2 (ja) 2021-03-26 2023-03-10 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021053119 2021-03-26
JP2021053119 2021-03-26
PCT/JP2022/012042 WO2022202566A1 (ja) 2021-03-26 2022-03-16 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023037718A Division JP7520175B2 (ja) 2021-03-26 2023-03-10 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Publications (3)

Publication Number Publication Date
JPWO2022202566A1 JPWO2022202566A1 (https=) 2022-09-29
JPWO2022202566A5 JPWO2022202566A5 (https=) 2023-02-21
JP7245399B2 true JP7245399B2 (ja) 2023-03-23

Family

ID=83397132

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022565919A Active JP7245399B2 (ja) 2021-03-26 2022-03-16 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物
JP2023037718A Active JP7520175B2 (ja) 2021-03-26 2023-03-10 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023037718A Active JP7520175B2 (ja) 2021-03-26 2023-03-10 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Country Status (5)

Country Link
US (1) US20240156773A1 (https=)
EP (1) EP4316484A4 (https=)
JP (2) JP7245399B2 (https=)
CN (1) CN116981454A (https=)
WO (1) WO2022202566A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023060897A (ja) * 2021-03-26 2023-04-28 日清オイリオグループ株式会社 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7851286B2 (ja) * 2023-11-24 2026-04-24 太陽油脂株式会社 糖代謝異常改善用油脂及び腸内環境改善用油脂

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010043098A (ja) 2002-02-28 2010-02-25 Japan Tobacco Inc エステル化合物及びその医薬用途
WO2016121675A1 (ja) 2015-01-26 2016-08-04 日清オイリオグループ株式会社 油脂
JP2018052818A (ja) 2015-01-28 2018-04-05 武田薬品工業株式会社 スルホンアミド化合物
JP2018534342A (ja) 2015-09-08 2018-11-22 モナッシュ ユニバーシティ リンパ指向性プロドラッグ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871768A (en) * 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
DE10130491A1 (de) * 2001-06-25 2003-04-17 Heirler Horst Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
WO2004022049A1 (ja) * 2002-09-05 2004-03-18 The Nisshin Oillio Group, Ltd. 痩身剤およびその飲食物
CN102791264B (zh) * 2010-03-31 2014-09-03 日清奥利友集团株式会社 用于预防或治疗糖尿病的油脂组合物
EP4316484A4 (en) * 2021-03-26 2024-12-18 The Nisshin Oillio Group, Ltd. Method for raising blood decanoic acid concentration, blood-decanoic-acid-concentration-raising agent, pharmaceutical composition, and food composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010043098A (ja) 2002-02-28 2010-02-25 Japan Tobacco Inc エステル化合物及びその医薬用途
WO2016121675A1 (ja) 2015-01-26 2016-08-04 日清オイリオグループ株式会社 油脂
JP2018052818A (ja) 2015-01-28 2018-04-05 武田薬品工業株式会社 スルホンアミド化合物
JP2018534342A (ja) 2015-09-08 2018-11-22 モナッシュ ユニバーシティ リンパ指向性プロドラッグ

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
KISHI, T. et al.，"Structured triglycerides containing medium-chain fatty acids and linoleic acid differently influenc，Nutrition Research，2002年，Vol.22，pp.1343-1351, ISSN: 0271-5317
MU, H. et al.，"Intestinal absorption of specific structured triacylglycerols"，Journal of Lipid Research，2001年，Vol.42，pp.792-798, ISSN: 0022-2275
PUJOL, J.B. et al.，"Coordination of GPR40 and Ketogenesis Signaling by Medium Chain Fatty Acids Regulates Beta Cell Fun，Nutrients，2018年，Vol.10, No.473，ISSN: 2072-6643
STRAARUP, E. M. et al.，"Structured Lipids Improve Fat Absorption in Normal and Malabsorbing Rats"，Nutrient and Metabolism，2000年，Vol.130，pp.2802-2808, ISSN: 1743-7075
長鎖脂肪酸，生化学辞典，第3版，p.883

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023060897A (ja) * 2021-03-26 2023-04-28 日清オイリオグループ株式会社 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物
JP7520175B2 (ja) 2021-03-26 2024-07-22 日清オイリオグループ株式会社 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Also Published As

Publication number Publication date
US20240156773A1 (en) 2024-05-16
CN116981454A (zh) 2023-10-31
JP2023060897A (ja) 2023-04-28
JP7520175B2 (ja) 2024-07-22
JPWO2022202566A1 (https=) 2022-09-29
EP4316484A1 (en) 2024-02-07
WO2022202566A1 (ja) 2022-09-29
EP4316484A4 (en) 2024-12-18

Similar Documents

Publication Publication Date Title
KR100740564B1 (ko) 공액화 리놀레산의 디글리세리드가 풍부한 유지조성물
CN1179026C (zh) 油脂组合物
CN1468059A (zh) 油/脂组合物
JP7520175B2 (ja) 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物
CN102791264B (zh) 用于预防或治疗糖尿病的油脂组合物
JP5718293B2 (ja) Ｇｉｐ上昇抑制剤
US20100210723A1 (en) Lipase inhibitor
WO2011080982A1 (ja) うつ病又はうつ状態の予防又は治療用油脂組成物
JP5739180B2 (ja) インスリン分泌促進用油脂組成物
JP2004075653A (ja) 体脂肪分解促進剤および飲食物
CN101426492A (zh) 饮食后血中胰岛素上升抑制剂
JP2022150493A (ja) 血中中鎖脂肪酸濃度の上昇方法、血中中鎖脂肪酸濃度上昇剤、医薬組成物、食品組成物
JP5702292B2 (ja) パーキンソン病患者の内臓脂肪減少抑制剤
JP5860803B2 (ja) 生体内の蛋白質の分解抑制剤
JP6470879B1 (ja) 抗炎症剤、抗炎症用医薬組成物、抗炎症用食品組成物
KR100684641B1 (ko) 유지 조성물, 이를 함유하는 식품 및 건강보조식품
Falana Addition of phospholipids to diet to enhance the bioavailability and incorporation of fish oil-omega-3-fatty acids
CN1188138C (zh) 精制海狗油在制备防治更年期综合症药中的应用
JP5211529B2 (ja) 肝機能改善剤
JP2019019069A (ja) 体脂肪低減剤
AU2024304933A1 (en) Substance and method for improving intestinal health and homeostasis, and nutrition and development of subject
JP2005225863A (ja) リパーゼ阻害剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221027

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221027

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20221027

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230131

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230221

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230310

R150 Certificate of patent or registration of utility model

Ref document number: 7245399

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250